Skip to main content
. 2021 Oct 23;13(11):3750. doi: 10.3390/nu13113750

Table 1.

Included and excluded articles.

Entries Found 1 Excluded Included
original work, but not experimental not original work not involving the single pure substance or the prostate/bladder cancer Preclinical Clinical
Prostate cancer Kaempferol 53 3 6 25 17 2
Myricetin 16 2 2 5 5 2
Fisetin 28 2 8 6 12 0
Bladder cancer Kaempferol 13 1 4 4 4 1
Myricetin 3 0 0 0 2 1
Fisetin 4 0 0 1 3 0

1 After removal of duplicate articles.